Kara L. Davis

16.3k total citations · 3 hit papers
74 papers, 4.4k citations indexed

About

Kara L. Davis is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kara L. Davis has authored 74 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 26 papers in Molecular Biology and 21 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kara L. Davis's work include CAR-T cell therapy research (30 papers), Acute Lymphoblastic Leukemia research (21 papers) and Single-cell and spatial transcriptomics (15 papers). Kara L. Davis is often cited by papers focused on CAR-T cell therapy research (30 papers), Acute Lymphoblastic Leukemia research (21 papers) and Single-cell and spatial transcriptomics (15 papers). Kara L. Davis collaborates with scholars based in United States, Italy and Israel. Kara L. Davis's co-authors include Garry P. Nolan, Sean C. Bendall, Erin F. Simonds, Dana Pe’er, Michelle D. Tadmor, El-ad David Amir, Jacob Levine, Smita Krishnaswamy, Astraea Jager and Harris G. Fienberg and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Kara L. Davis

67 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis

2015 1.3k citations Jacob Levine, Erin F. Simonds et al. Cell profile →
viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia

2013 1.1k citations El-ad David Amir, Kara L. Davis et al. profile →
Single-Cell Trajectory Detection Uncovers Progression and Regulatory Coordination in Human B Cell Development

2014 631 citations Sean C. Bendall, Kara L. Davis et al. Cell profile →

Peers

Kara L. Davis

IMMUN

ONCOL

BIOPH

Eli R. Zunder United States

Rachel Finck United States

Michelle D. Tadmor United States

Roser Vento‐Tormo United Kingdom

Jacob Levine United States

Erin F. Simonds United States

Iain C. Macaulay United Kingdom

Karen Sachs United States

Greg Finak United States

Nikolay Samusik United States

Eli R. Zunder United States

Kara L. Davis

3.0k ×1.1

1.2k ×0.8

IMMUN

619 ×0.6

ONCOL

630 ×0.8

BIOPH

356 ×0.8

Citations per year, relative to Kara L. Davis Kara L. Davis (= 1×) peers Eli R. Zunder

Countries citing papers authored by Kara L. Davis

Since Specialization

Citations

This map shows the geographic impact of Kara L. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara L. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara L. Davis more than expected).

Fields of papers citing papers by Kara L. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kara L. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara L. Davis. The network helps show where Kara L. Davis may publish in the future.

Co-authorship network of co-authors of Kara L. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Kara L. Davis. A scholar is included among the top collaborators of Kara L. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara L. Davis. Kara L. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lamble, Adam J., Sandra D. Bohling, Kara L. Davis, et al.. (2025). Harmonization on defining B‐cell recovery post CD19‐CAR T‐cell therapy in B‐cell acute lymphoblastic leukemia: An international consensus statement. HemaSphere. 9(11). e70247–e70247.

Zhang, Amy, Kara L. Davis, Sneha Ramakrishna, et al.. (2025). Establishing Concordance of Next Generation Sequencing and Flow Cytometry Measures of B-Cell Recovery Post-CAR T Cell Therapy in B-ALL. Transplantation and Cellular Therapy. 31(2). S205–S206.

Pai, Sara I., Julia C. Buckingham, Yvonne M. Carter, et al.. (2025). A Clinical Consensus Statement on Pulmonary Recurrent Respiratory Papillomatosis. The Laryngoscope. 135(12). 4642–4650. 1 indexed citations

Srinagesh, Hrishikesh K., Anne Marijn Kramer, John H. Baird, et al.. (2025). Clinical and Cytokine Features of Immune Effector Cell–Associated Hemophagocytic Lymphohistiocytosis–Like Syndrome. Blood Cancer Discovery. 7(2). 225–233.

Aftandilian, Catherine, et al.. (2024). Plasma microbial cell‐free DNA following chimeric antigen receptor T cell therapy in pediatric patients with relapsed/refractory leukemia. European Journal Of Haematology. 113(2). 208–217. 1 indexed citations

Yao, Catherine & Kara L. Davis. (2024). Correlative studies reveal factors contributing to successful CAR-T cell therapies in cancer. Cancer and Metastasis Reviews. 44(1). 15–15. 2 indexed citations

Davis, Kara L., et al.. (2023). Advances in Clinical Mass Cytometry. Clinics in Laboratory Medicine. 43(3). 507–519. 5 indexed citations

Davis, Kara L., Elizabeth Fox, Joel M. Reid, et al.. (2022). A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412. Clinical Cancer Research. 28(23). 5088–5097. 43 indexed citations

Reschke, Agnes, Rebecca M. Richards, Stephanie M. Smith, et al.. (2022). Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patients. Frontiers in Oncology. 12. 1033993–1033993. 2 indexed citations

10.

Domizi, Pablo, Jolanda Sarno, Astraea Jager, et al.. (2021). Ikaros Mediates Antigen Escape Following CD19 CAR T Cell Therapy in r/r B-ALL. Blood. 138(Supplement 1). 613–613. 6 indexed citations

11.

Chae, Hee-Don, Fieke W. Hoff, Benedetta Accordi, et al.. (2020). RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit. Oncotarget. 11(25). 2387–2403. 17 indexed citations

12.

Díaz-Flores, Ernesto, Kyle Beckman, Kara L. Davis, et al.. (2019). Bcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia. Cancer Research. 79(9). 2339–2351. 49 indexed citations

13.

Jager, Astraea, Pablo Domizi, Mara Pavel-Dinu, et al.. (2019). High-efficiency CRISPR induction of t(9;11) chromosomal translocations and acute leukemias in human blood stem cells. Blood Advances. 3(19). 2825–2835. 25 indexed citations

14.

Davis, Kara L., et al.. (2019). A novel platform for isotype-specific testing of autoantibodies. PLoS ONE. 14(2). e0211596–e0211596.

15.

Anchang, Benedict, Kara L. Davis, Harris G. Fienberg, et al.. (2018). DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity. Proceedings of the National Academy of Sciences. 115(18). E4294–E4303. 35 indexed citations

16.

Davis, Kara L., Zinaida Good, Jolanda Sarno, et al.. (2018). Single-Cell Developmental Classification of B-Cell Precursor Acute Lymphoblastic Leukemia at Diagnosis Reveals Predictors of Relapse. Experimental Hematology. 64. S33–S34. 1 indexed citations

17.

Good, Zinaida, Jolanda Sarno, Astraea Jager, et al.. (2018). Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse. Nature Medicine. 24(4). 474–483. 85 indexed citations

18.

Porpiglia, Ermelinda, Nikolay Samusik, Andrew Tri Van Ho, et al.. (2017). High-resolution myogenic lineage mapping by single-cell mass cytometry. Nature Cell Biology. 19(5). 558–567. 81 indexed citations

19.

Levine, Jacob, Erin F. Simonds, Sean C. Bendall, et al.. (2015). Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis. Cell. 162(1). 184–197. 1279 indexed citations breakdown →

20.

Davis, Kara L., Samir S. Shah, Gary Frank, & Stephen C. Eppes. (2008). Why Are Young Infants Tested for Herpes Simplex Virus?. Pediatric Emergency Care. 24(10). 673–678. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact